Skip to main content
Fig. 3 | BMC Pulmonary Medicine

Fig. 3

From: Percepta Genomic Sequencing Classifier and decision-making in patients with high-risk lung nodules: a decision impact study

Fig. 3

Distribution of physician survey taker assessment of the risk of malignancy. A Percepta GSC very high risk up-classification resulted in a signficantly higher mean assessment of ROM in the independent cohort with Percepta GSC compared to the independent cohort without a GSC result (left). Providing a very high risk result significantly increased the mean assessment of ROM in the pre–post cohort (right). In all three cohorts, physicians frequently assessed ROM to be < 60%. ROM risk of malignancy

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us